Join
Live feed
·
INSIDERFilingvia Quantisnow
Cardiff Oncology Inc. logo

Director Pace Gary W bought $940,199 worth of shares (361,615 units at $2.60), increasing direct ownership by 50% to 1,047,876 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CRDF· Cardiff Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRDF (Cardiff Oncology Inc.) and more on Quantisnow.